enVVeno Medical (NVNO) Equity Average (2018 - 2026)

enVVeno Medical has reported Equity Average for 9 years, with the latest figure at $25.4 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 36.77% year-over-year to $25.4 million; the trailing twelve-month figure through Mar 2026 stood at $25.4 million (down 36.77% YoY), and the FY2025 full-year result was $34.6 million, down 21.58% from the prior year.
• Equity Average for Q1 2026 stood at $25.4 million, down from $28.3 million in the prior quarter.
• The five-year high for Equity Average was $52.9 million in Q1 2022, with the low at $25.4 million in Q1 2026.
• Average Equity Average over 5 years is $38.3 million, with a median of $40.2 million recorded in 2025.
• Year-over-year, Equity Average surged 110.98% in 2022 and sank 39.79% in 2023.
• Tracing NVNO's Equity Average over 5 years: stood at $40.7 million in 2022, then retreated by 12.64% to $35.6 million in 2023, then gained by 25.89% to $44.8 million in 2024, then tumbled by 36.81% to $28.3 million in 2025, then decreased by 10.07% to $25.4 million in 2026.
• The last three Equity Average figures came in at $25.4 million (Q1 2026), $28.3 million (Q4 2025), and $31.3 million (Q3 2025), per Business Quant data.

Peer Comparison